Limitations in the cell and gene therapy cold chain and how to overcome them

Patient cells are the foundations for cell and gene therapies, products that are increasing in quantity and in their diverse treatment applications. However, cell and gene therapy supply chains introduce specific challenges that differ from those associated with biologics. The development, manufacturing, and transport of cell and gene therapies require consideration and care, including temperature controls and tracking and verifying the chain of custody.

Other key metrics for a strong cell and gene therapy cold chain include: product traceability, temperature range integrity, proper handling and receipt of the product.

What goes into building a strong cold chain for cell and gene therapies? How will it affect the success of your product? Register for the webinar today to hear from World Courier experts.

Who should join? Supply chain managers, product owners for cell and gene therapy, portfolio managers and research leads

Live Webinar
Time:  11am - 12pm

Date: 14 Feb 2023, Tuesday

Speakers

What World Courier can offer for Cell and Gene therapy transport and introduction to packaging solutions - Stanley Soh, Senior Regional Quality Manager

Building and executing a resilient CGT supply chain - Mervin Sulistyo - Value Engineering Consultant, APAC